Where does Parkinson disease pathology begin in the brain?

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 5, 2002, Pages 413-426

  Del Tredici, Kelly ^a   Rüb, Udo ^a   De Vos, Rob A I ^a   Bohl, Jürgen R E ^a   Braak, Heiko ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anterior olfactory nucleus; Extranigral pathology; Lewy body neurite; Lower brainstem; Parkinson disease; Pathoanatomy; synuclein

Indexed keywords

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BRAIN STEM; CATECHOLAMINE NERVE CELL; CINGULATE GYRUS; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; FEMALE; GIGANTOCELLULAR RETICULAR NUCLEUS; GLOSSOPHARYNGEAL NERVE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LEWY BODY; LOCUS CERULEUS; MAJOR CLINICAL STUDY; MALE; MEYNERT BASAL NUCLEUS; NERVE DEGENERATION; NERVE PROJECTION; OLFACTORY BULB; OLFACTORY NUCLEUS; OLFACTORY TRACT; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TEMPORAL CORTEX; VAGUS NERVE;

EID: 0036094576     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.5.413     Document Type: Article

References (98)

1. Alzheimer-Parkinson disease overlap: Neuropathology
2. Neuropathology of Alzheimer's disease and other dementias
3. Synucleinopathies: Clinical and pathological implications
4. Diagnostic criteria for Parkinson disease
5. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
6. The clinical features of Parkinson's disease in 100 histologically proven cases
7. Neuropathology of Parkinson's disease
8. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease
9. Paralysis agitans. I. Pathologische Anatomie
10. Pathology and biology of the Lewy body
11. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
12. Tau and synuclein and their role in neuropathology
13. Neuropathology of synuclein aggregates: New insights into mechanism of neurodegenerative diseases
14. Pathobiology of the Lewy body
15. From genetics to pathology: Tau and α-synuclein assemblies in neurodegenerative diseases
16. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity
17. Aggregation of neurofilament and αsynuclein proteins in Lewy bodies-Implications for the pathogenesis of Parkinson disease and Lewy body dementia
18. Alpha-B-Crystallin in Neuropathology
19. α-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei
20. Pathoanatomy of Parkinson's disease
21. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases
22. Aging in the central nervous system
23. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease
24. Amygdala pathology in Parkinson's disease
25. Parkinson's disease: Affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system
26. Age-related loss of dorsal vagal neurons in Parkinson's disease
27. Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease
28. Is Parkinson's disease a primary olfactory disorder?
29. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson's disease and in progressive supranuclear palsy
30. Pathology of Parkinson's disease: Changes other than the nigrostriatal pathway
31. The hypothalamus in Parkinson's disease
32. The pedunculopontine nucleus and Parkinson's disease
33. Parkinson's disease: The thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology
34. The pathology of certain medullary nuclei in parkinsonism
35. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
36. Olfactory dysfunction in Parkinson's disease
37. Olfaction in neurodegenerative disease. A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's disease
38. Olfactory impairment in Parkinson's disease
39. Preclinical (premotor) Parkinson's disease
40. Subcortical limbic system projections to caudal brainstem and spinal cord
41. The emotional motor system
42. The greater limbic system, the emotional motor system and the brain
43. Clinical features and natural history of Parkinson's disease (special consideration of aging)
44. Relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei
45. Neuropathological stageing of Alzheimer-related changes
46. New neuropathological criteria for Alzheimer's disease
47. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections
48. Human NACP/α-synuclein distribution in Lewy body disease
49. Alphasynuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components
50. Architectonics as seen by lipofuscin stains
51. Alphasynuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique
52. Über die Kerngebiete des menschlichen Hirnstammes. II. Die Raphekerne
53. Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult
54. Correspondence of melanin-pigmented neurons in human brain with A1-A14 catecholamine cell groups
55. Reticular formation of the pons and medulla
56. Human intermediate reticular zone: A cytoand chemoarchitectonic study
57. Frequency of stages of Alzheimer-related lesions in different age categories
58. Distinct nuclear groups in the lower brainstem consistently develop Alzheimer's disease-associated neurofibrillary changes
59. The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans
60. Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system
61. Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by α-synuclein immunocytochemistry
62. Distribution of monoaminesynthesizing neurons in the human medulla oblongata
63. Autonomic regulatory centers in the medulla oblongata
64. Olfactory bulb changes in Alzheimer's disease
65. Olfactory system
66. The anterior olfactory nucleus in Parkinson's disease
67. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease
68. Accumulation of NACP/α-synuclein in Lewy body disease and multiple system atrophy
69. Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
70. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease
71. Widespread alterations of α-synuclein in multiple system atrophy
72. Accumulation of NACP/αsynuclein in Lewy body disease and multiple system atrophy
73. Ageing and Parkinson's disease: Substantia nigra regional selectivity
74. Concentric hyalin intraneuronal inclusions of Lewy type in the brain of elderly persons (50 incidental cases): Relationship to parkinsonism
75. Functional neuropathology in Parkinson's disease
76. Identification of normal and pathological aging
77. The frequency of Lewy bodies in a consecutive autopsy series
78. Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease
79. How accurately can Parkinson's disease be diagnosed?
80. Morphological and functional imaging studies of the diagnosis and progression of Parkinson's disease
81. 18F]dopa- PET
82. Early diagnosis in Parkinson's disease
83. 123I]β-CIT and SPECT: Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy
84. Separating Parkinson's disease from normality
85. Investigation of autonomic disorders
86. Criteria for diagnosing Parkinson's disease
87. Parkinson's disease and other basal ganglion disorders
88. Autonomic nervous system disturbances in Parkinson's disease
89. Cardiovascular reflexes and autonomic dysfunction in Parkinson's disease
90. The audiospinal reaction in Parkinsonian patients reflects functional changes in reticular nuclei
91. Functional changes of brainstem reflexes in Parkinson's disease. Conditioning of blink reflex R2 component by paired and index finger stimulation
92. Neurophysiological characterization of parkinsonian syndromes
93. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease
94. Event-related brain potentials to attended and ignored olfactory and trigeminal stimuli
95. Olfaction in Parkinson's disease: Methods of assessment and clinical relevance
96. Olfactory event-related potentials and aging: Normative data
97. Topography and morphology of catecholaminergic neurons in the solitary and dorsal vagal nuclear complex in the human brainstem